In line with our focus this month on all aspects of influenza, we spoke to Ed Schmidt, project manager of the Universal Influenza Vaccines Secured (UNISEC) consortium, about its aim to develop a universal flu vaccine.
In our latest piece, Janet Daly discusses the species jump of influenza A virus from horses to dogs and the insights this gives into the factors involved in interspecies transmission events.
Researchers have designed potent peptide fusion inhibitors that can neutralize a broad range of influenza viruses and could present a promising avenue for future therapeutics.
Researchers have demonstrated the having a positive mood on the day of flu vaccination may predict and even improve vaccine effectiveness.
A newly identified genetic variation in the IFITM3 gene has been associated with the severity of influenza in US patients, and could have predictive value to identify high-risk individuals.
Researchers have identified the primary enzymatic source of reactive oxygen species in humans, discovering that this enzyme exacerbates viral pathogenicity and suggesting that it could be an antiviral target.
The threat of future influenza pandemics demands that public health, governments and health care providers grapple with complex communication challenges. Read more on attitudes towards influenza in our latest opinion piece.
A Phase I clinical trial has demonstrated that microneedle patches for flu vaccinations are safe, well-tolerated, immunogenic and also preferred by participants over intramuscular injection.
Researchers have discovered that investigational cancer drug, BEZ235, may reduce the severity of influenza infection by altering host-cell metabolism, representing new treatment avenues.
Recent studies suggest that the risk of a heart attack could be increased 17-fold during the 7 days after a respiratory infection.
